DrugPatentWatch Database Preview
Drugs in Development Information for Ganetespib
Email this page to a colleague
What is the development status for investigational drug Ganetespib?
Ganetespib is an investigational drug.
There have been 31 clinical trials for Ganetespib.
The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2014.
The most common disease conditions in clinical trials are Lung Neoplasms, Breast Neoplasms, and Carcinoma, Non-Small-Cell Lung. The leading clinical trial sponsors are Synta Pharmaceuticals Corp., Dana-Farber Cancer Institute, and Emory University.
There are five hundred and twenty-five US patents protecting this investigational drug and five international patents.
Summary for Ganetespib
| US Patents | 525 |
| International Patents | 5,585 |
| US Patent Applications | 1,078 |
| WIPO Patent Applications | 771 |
| Japanese Patent Applications | 434 |
| Clinical Trial Progress | Phase 2 (2014-10-01) |
| Vendors | 61 |
Recent Clinical Trials for Ganetespib
| Title | Sponsor | Phase |
|---|---|---|
| European Trial on Enhanced DNA Repair Inhibition in Ovarian Cancer | European Commission | Phase 2 |
| European Trial on Enhanced DNA Repair Inhibition in Ovarian Cancer | Universitaire Ziekenhuizen Leuven | Phase 2 |
| A Pilot Preoperative Trial of Ganetespib With Paclitaxel for Triple-Negative Breast Cancer | University of Chicago | N/A |
Clinical Trial Summary for Ganetespib
Top disease conditions for Ganetespib
Top clinical trial sponsors for Ganetespib
US Patents for Ganetespib
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Ganetespib | Get Started Free | Compounds and their methods of use | Agios Pharmaceuticals, Inc. (Cambridge, MA) | Get Started Free |
| Ganetespib | Get Started Free | Substituted indole Mcl-1 inhibitors | Vanderbilt University (Nashville, TN) | Get Started Free |
| Ganetespib | Get Started Free | Pyrrolidinone derivatives as MetAP-2 inhibitors | Merck Patent GmbH (Darmstadt, DE) | Get Started Free |
| Ganetespib | Get Started Free | Bicyclic bromodomain inhibitors | Zenith Epigenetics Ltd. (Calgary, AB, CA) | Get Started Free |
| Ganetespib | Get Started Free | Small molecule HSP70 inhibitors | The Trustees of the University of Pennsylvania (Philadelphia, PA) The Wistar Institute of Anatomy and Biology (Philadelphia, PA) | Get Started Free |
| Ganetespib | Get Started Free | Glutaminase inhibitors and method of use | Agios Pharmaceuticals, Inc. (Cambridge, MA) | Get Started Free |
| Ganetespib | Get Started Free | Constructs targeting AFP peptide/MHC complexes and uses thereof | EUREKA THERAPEUTICS, INC. (Emeryville, CA) | Get Started Free |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Ganetespib
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Ganetespib | Australia | AU2015231053 | 2034-03-21 | Get Started Free |
| Ganetespib | Brazil | BR112016021620 | 2034-03-21 | Get Started Free |
| Ganetespib | Canada | CA2943339 | 2034-03-21 | Get Started Free |
| Ganetespib | China | CN106231900 | 2034-03-21 | Get Started Free |
| Ganetespib | Eurasian Patent Organization | EA201691896 | 2034-03-21 | Get Started Free |
| Ganetespib | European Patent Office | EP3119199 | 2034-03-21 | Get Started Free |
| Ganetespib | Israel | IL247921 | 2034-03-21 | Get Started Free |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
